Shortage of pathologists only adds to the challenges of providing high quality anatomic pathology testing services
DATELINE: Hangzhou, China—More than 1,200 Chinese pathologists and medical laboratory scientists assembled this weekend in a city marked by 1,500 years of history. The occasion was the first-ever combined meeting of the Chinese Society of Pathology and the Pathology Branch of the Chinese Medical Association.
Across the globe, pathologists and clinical laboratory professionals regularly hear about the rapid economic growth in China. This country is modernizing at an astounding rate and the evidence is easy to see in its major cities. That is certainly true here in Hanghzou, which has a population of 8.7 million people and is the anchor city for Zhejiang Province, with a population of approximately 54.4 million. It has many new buildings in its downtown and construction cranes are visible in every direction.
IVD manufacturers often introduce their newest technologies in Europe before the United States
DATELINE: BERLIN, GERMANY: With so many changes happening to clinical pathology laboratory testing in developed nations around the world, there is keen interest in evolving technologies, along with new medical laboratory instruments and automation products that clinical biochemists and pathologists will use, in the near future, to improve the quality of the clinical laboratory testing services they provide to physicians.
Here at the IFCC-WorldLab Berlin 2011 conference, pathologists and clinical chemists from the United States got an early peek at some of the latest and newest solutions developed by the world’s largest in vitro diagnostics (IVD) manufacturers. Many products on display at the IFCC WorldLab Exhibition have only been cleared for sale by the European Union. These products do not have clearance by the U.S. Food and Drug Administration (FDA) in the United States for sale and use in this country.